
    
      This is a prospective, multi-center, non-randomized, single-arm, post-market,
      non-interventional study of treatment with the TREO Abdominal Stent-Graft in subjects with
      Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms. The study will include a
      minimum of 300 subjects treated with the TREO Abdominal Stent-Graft at up to 55
      investigational sites in the US.

      The primary objective is the collection of real world safety and effectiveness outcomes of
      the TREO Abdominal Stent-Graft System in an all-comers population eligible for the
      endovascular treatment of AAA in routine clinical practice, with emphasis on subjects that
      experience a device stent-strut or barb fracture.
    
  